0082N0 — Kanaph Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Kanaph Therapeutics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4,296	17,272	16,813	9,218
Net Total Accounts Receivable
Net Total Receivables	406	185	349	3,989
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4,903	17,828	17,834	13,937
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,785	2,073	1,700	1,016
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	7,010	20,217	20,023	15,461
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	44,750	70,146	97,412	2,373
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	45,035	70,353	97,708	3,083
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	-38,025	-50,135	-77,685	12,378
Total Liabilities & Shareholders' Equity	7,010	20,217	20,023	15,461
Total Common Shares Outstanding